World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
55
Citations
11116
World Ranking
3813
National Ranking
1493

David M. Shlaes publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David M. Shlaes sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 124 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David M. Shlaes D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Shlaes sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 55 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David M. Shlaes is affiliated with Case Western Reserve University in the United States. Their research primarily focuses on the fields of immunology and microbiology, with a particular emphasis on applied microbiology and biotechnology, economics and econometrics, molecular medicine, immunology, and complementary and alternative medicine.

The scientist's work covers several main topics, including antibiotic use and resistance, pharmaceutical economics and policy, antibiotic resistance in bacteria, biosimilars and bioanalytical methods, and complementary and alternative medicine studies.

David M. Shlaes has published papers in several prominent venues. The most frequent publication venues include:

  • ACS Infectious Diseases
  • Clinical Infectious Diseases

Recent published papers by David M. Shlaes include:

  • "Antibacterial Drugs: The Last Frontier," 2020, ACS Infectious Diseases
  • "Innovation, Nontraditional Antibacterial Drugs, and Clinical Utility," 2021, ACS Infectious Diseases
  • "Can Europe Pull It Together?", 2020, Clinical Infectious Diseases
  • "Personal View of the Antibiotic Value Proposition," 2020, ACS Infectious Diseases

Best Publications

  • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

    David M. Shlaes;Dale N. Gerding;Joseph F. John;William A. Craig

  • Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

    Joseph W. Chow;Michael J. Fine;David M. Shlaes;John P. Quinn

  • Transcription Profiling-Based Identification of Staphylococcus aureus Genes Regulated by the agr and/or sarA Loci

    P. M. Dunman;E. Murphy;S. Haney;D. Palacios

  • Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center

    Louis B. Rice;Elizabeth C. Eckstein;Jerome DeVente;David M. Shlaes

  • Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients.

    R. A. Salata;M. M. Lederman;D. M. Shlaes;M. R. Jacobs

  • Infections due to Lancefield group C streptococci.

    Robert A. Salata;Phillip I. Lerner;David M. Shlaes;K. V. Gopalakrishna

  • Serogroup-Specific Epidemiology of Streptococcus pneumoniae: Associations with Age, Sex, and Geography in 7,000 Episodes of Invasive Disease

    J. A. G. Scott;A. J. Hall;R. Dagan;J. M. S. Dixon

  • The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.

    Unknown

  • Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256

    Unknown

  • Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.

    J W Chow;A Kuritza;D M Shlaes;M Green

  • Serious infections caused by Bacillus species

    Robert Sliman;Susan Rehm;David M. Shlaes

  • The FDA Reboot of Antibiotic Development

    David M. Shlaes;Dan Sahm;Carol Opiela;Brad Spellberg

  • Infections Due to Lancefield Group F and Related Streptococci (S. milleri, S. anginosus)

    David M. Shlaes;Phillip I. Lerner;Emanuel Wolinsky;K. V. Gopalakrishna

  • Enterococcal Bacteremia Without Endocarditis

    David M. Shlaes;Josef Levy;Emanuel Wolinsky

  • Decreased Teicoplanin Susceptibility of Methicillin-Resistant Strains of Staphylococcus aureus

    Jean Luc Mainardi;David M. Shlaes;David M. Shlaes;Richard V. Goering;Janet H. Shlaes;Janet H. Shlaes

  • Inducible resistance to vancomycin in Enterococcus faecium D366.

    Unknown

  • Vancomycin susceptibility and identification of motile enterococci.

    S Vincent;R G Knight;M Green;D F Sahm

  • Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.

    D M Shlaes;L Etter;L Gutmann

  • Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.

    M R Jacobs;S C Aronoff;S Johenning;D M Shlaes

  • Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex.

    D M Shlaes;J H Shlaes;S Vincent;L Etter

  • White paper: Recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens

    Brad Spellberg;Eric P. Brass;John S. Bradley;Roger J. Lewis

  • Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria.

    Alexey Ruzin;Guy Singh;Anatoly Severin;Youjun Yang

  • Further evidence that a cell wall precursor [C(55)-MurNAc-(peptide)-GlcNAc] serves as an acceptor in a sorting reaction.

    Alexey Ruzin;Anatoly Severin;Frank Ritacco;Keiko Tabei

  • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

    David M. Shlaes;Dale N. Gerding;Joseph F. John;William A. Craig

  • DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level.

    S. Donabedian;J. W.F Chow;D. M. Shlaes;M. Green

Frequent Co-Authors

Louis B. Rice
Louis B. Rice Brown University
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Michael R. Jacobs
Michael R. Jacobs University Hospitals of Cleveland
Patricia A. Bradford
Patricia A. Bradford AstraZeneca (United Kingdom)
Robert A. Salata
Robert A. Salata Case Western Reserve University
Steven J. Projan
Steven J. Projan Rutgers, The State University of New Jersey
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
William A. Craig
William A. Craig University of Wisconsin–Madison
Dale N. Gerding
Dale N. Gerding Veterans Health Administration

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring complementary online degrees can broaden career opportunities in healthcare, research, and public health. For example, many professionals pursue an online MPH programs easy to get into to gain expertise in public health management alongside their scientific background.

A microbiology degree can also serve as a foundation for roles in specialized healthcare fields. Those aiming to work with children might consider careers like becoming a child life specialist, which offers competitive roles and a strong child life specialist salary with bachelor degree.

For individuals with unique challenges, such as those with criminal records, selecting the best degree for felons can help them transition into careers in science and healthcare, including microbiology-related fields.

Additionally, microbiology graduates interested in nursing might explore pathways to become a functional medicine nurse practitioner, a role known for its holistic approach and favorable functional medicine nurse salary.

By combining microbiology with these complementary degrees and career paths, graduates can unlock diverse opportunities in research, healthcare, and beyond.

Best Scientists Citing David M. Shlaes

Trending Scientists

Recently Published Articles